Income Statement Ryoden Corporation

Stocks

8084

JP3976200000

Electrical Components & Equipment

Delayed Japan Exchange Other stock markets 08:22:18 28/07/2026 +04			5-day change	1st Jan Change
4,110.00 ^JPY	+4.71%		+4.85%	+13.71%

07-03	Ryoden Corporation completed the acquisition of Topas Electronic Vertriebsges. Mbh.	CI
06-05	Ryoden Corporation 's Equity Buyback announced on June 4, 2026, has closed with 60,000 shares, representing 0.28% for ¥235.8 million.	CI

6fd4528cabf9347ce.EFT0DEjhfex1KWMm9U1cG9ZRq7tu_iaC62Z0hI7xhFw.eXnHeCmmON8ZbCZhryMsTaU3_doAsU3O2yEn9bqU_gZCBIRhCYA0wRlcFA

Published financial data: RYODEN CORPORATION

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: March	2022	2023	2024	2025	2026
Revenues	229B	260B	259B	216B	213B
Total Revenues	229B	260B	259B	216B	213B
Cost of Goods Sold, Total	203B	231B	230B	188B	183B
Gross Profit	26.15B	29.48B	29.23B	27.54B	29.76B
Selling General & Admin Expenses, Total	18.73B	19.7B	20.5B	21.54B	23.97B
Provision for Bad Debts	42M	-	-	-	-
Depreciation & Amortization - (IS)	353M	409M	405M	516M	538M
Other Operating Expenses, Total	19.13B	20.1B	20.9B	22.06B	24.51B
Operating Income	7.02B	9.38B	8.33B	5.48B	5.24B
Interest Expense, Total	-24M	-56M	-89M	-90M	-71M
Interest And Investment Income	208M	208M	326M	474M	491M
Net Interest Expenses	184M	152M	237M	384M	420M
Income (Loss) On Equity Invest.	80M	-39M	28M	65M	50M
Currency Exchange Gains (Loss)	-18M	-530M	-439M	-176M	-21M
Other Non Operating Income (Expenses)	73M	118M	106M	254M	92M
EBT, Excl. Unusual Items	7.34B	9.08B	8.26B	6.01B	5.79B
Gain (Loss) On Sale Of Investments	-26M	-738M	81M	463M	1.75B
Gain (Loss) On Sale Of Assets	-16M	7M	-4M	-2M	-20M
Asset Writedown	-	-1.44B	-	-	-
Other Unusual Items	-1M	1.44B	72M	-	-203M
EBT, Incl. Unusual Items	7.3B	8.35B	8.41B	6.47B	7.31B
Income Tax Expense	2.29B	2.98B	2.67B	1.77B	2.03B
Earnings From Continuing Operations	5B	5.37B	5.74B	4.7B	5.28B
Net Income to Company	5B	5.37B	5.74B	4.7B	5.28B
Minority Interest	-	-	-1M	-2M	-4M
Net Income - (IS)	5B	5.37B	5.74B	4.7B	5.28B
Net Income to Common Incl Extra Items	5B	5.37B	5.74B	4.7B	5.28B
Net Income to Common Excl. Extra Items	5B	5.37B	5.74B	4.7B	5.28B
Per Share Items
Net EPS - Basic	229.98	245.91	262.43	214.77	244.84
Basic EPS - Continuing Operations	229.98	245.91	262.43	214.77	244.84
Basic Weighted Average Shares Outstanding	21.76M	21.82M	21.86M	21.88M	21.54M
Net EPS - Diluted	228.7	244.73	261.33	214.04	244.17
Diluted EPS - Continuing Operations	228.7	244.73	261.33	214.04	244.17
Diluted Weighted Average Shares Outstanding	21.88M	21.93M	21.95M	21.96M	21.6M
Normalized Basic EPS	210.84	260.1	236.09	171.58	167.66
Normalized Diluted EPS	209.66	258.84	235.1	170.98	167.2
Dividend Per Share	56	74	106	106	138
Payout Ratio	23.84	26.03	33.07	52.53	49.29
Supplemental Items
EBITDA	7.43B	9.95B	8.97B	6.26B	6.04B
EBITA	7.02B	9.38B	8.33B	5.48B	5.24B
EBIT	7.02B	9.38B	8.33B	5.48B	5.24B
EBITDAR	8.83B	11.43B	10.69B	8.11B	8.21B
Effective Tax Rate - (Ratio)	31.42	35.74	31.76	27.35	27.81
Normalized Net Income	4.59B	5.68B	5.16B	3.75B	3.61B
Non-Cash Pension Expense	-33M	4M	33M	-177M	-123M
Supplemental Operating Expense Items
Selling and Marketing Expenses	2.52B	2.7B	2.68B	2.59B	2.86B
Research And Development Expense From Footnotes	14M	13M	34M	37M	24M
Net Rental Expense, Total	1.4B	1.48B	1.72B	1.85B	2.17B
Imputed Operating Lease Interest Expense	438M	312M	368M	456M	506M
Imputed Operating Lease Depreciation	965M	1.17B	1.35B	1.39B	1.66B

Fiscal Period: March	2022	2023	2024	2025	2026
Assets
Cash And Equivalents	11.59B	11.63B	19.28B	33.31B	33.46B
Short Term Investments	52M	168M	37M	-	128M
Total Cash And Short Term Investments	11.64B	11.8B	19.32B	33.31B	33.59B
Accounts Receivable, Total	73.44B	79.79B	81.68B	58.63B	58.34B
Other Receivables	-	-	-	-	9.39B
Total Receivables	73.44B	79.79B	81.68B	58.63B	67.73B
Inventory	32.85B	37.88B	35.2B	27.3B	27.27B
Deferred Tax Assets Current	-	-	-	-	-
Other Current Assets, Total	8.16B	6.85B	3.97B	6.56B	3.27B
Total Current Assets	126B	136B	140B	126B	132B
Net Property Plant And Equipment	3.76B	5.44B	5.46B	5.2B	5.95B
Long-term Investments	9.85B	8B	9.24B	8.88B	11.21B
Other Intangibles, Total	806M	917M	1.04B	1.98B	5.16B
Deferred Tax Assets Long-Term	453M	356M	105M	136M	130M
Deferred Charges Long-Term	-	7M	5M	3M	1M
Other Long-Term Assets, Total	1M	2M	2M	1M	2M
Total Assets	141B	151B	156B	142B	154B
Liabilities
Accounts Payable, Total	54.89B	57.44B	55.96B	39.63B	43.99B
Short-term Borrowings	822M	1.63B	1.44B	1.15B	987M
Current Income Taxes Payable	1.63B	1.9B	1.24B	276M	1.18B
Other Current Liabilities	5.24B	4.58B	6.43B	8.24B	9.47B
Total Current Liabilities	62.58B	65.55B	65.07B	49.3B	55.63B
Long-Term Debt	-	1.78B	1.77B	1.47B	1.26B
Pension & Other Post Retirement Benefits	2.82B	2.98B	378M	279M	-
Deferred Tax Liability Non Current	-	-	-	-	2.03B
Other Non Current Liabilities	802M	836M	1.72B	1.74B	862M
Total Liabilities	66.2B	71.15B	68.95B	52.78B	59.77B
Common Stock, Total	10.33B	10.33B	10.33B	10.33B	10.33B
Additional Paid In Capital	7.45B	7.5B	7.52B	7.36B	7.41B
Retained Earnings	55.46B	59.39B	63.23B	64.16B	66.83B
Treasury Stock	-800M	-742M	-726M	-128M	-71M
Comprehensive Income and Other	2.32B	3.41B	6.72B	7.48B	10.01B
Total Common Equity	74.76B	79.9B	87.07B	89.2B	94.52B
Minority Interest	-	2M	8M	10M	15M
Total Equity	74.76B	79.9B	87.08B	89.21B	94.53B
Total Liabilities And Equity	141B	151B	156B	142B	154B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	21.76M	21.84M	21.86M	21.51M	21.56M
ECS Total Common Shares Outstanding	21.76M	21.84M	21.86M	21.51M	21.56M
Book Value / Share	3.44K	3.66K	3.98K	4.15K	4.38K
Tangible Book Value	73.96B	78.98B	86.04B	87.22B	89.36B
Tangible Book Value Per Share	3.4K	3.62K	3.94K	4.05K	4.15K
Total Debt	822M	3.42B	3.22B	2.62B	2.24B
Net Debt	-10.82B	-8.38B	-16.1B	-30.7B	-31.35B
Debt Equivalent of Unfunded Proj. Benefit Obligation	2.82B	2.98B	378M	279M	-2.19B
Debt Equivalent Oper. Leases	11.22B	11.82B	13.72B	14.78B	17.33B
Minority Interest, Total (Incl. Fin. Div)	-	2M	8M	10M	15M
Inventories - Finished Goods, Total	32.85B	37.88B	35.2B	27.3B	27.27B
Full Time Employees	1.21K	1.24K	1.36K	1.45K	1.56K
Accumulated Allowance for Doubtful Accounts (Supple)	27M	29M	30M	16M	15M

Fiscal Period: March	2022	2023	2024	2025	2026
Net Income	7.3B	8.35B	8.41B	6.47B	7.31B
Depreciation & Amortization - CF	409M	572M	648M	777M	800M
Depreciation & Amortization, Total	409M	572M	648M	777M	800M
(Gain) Loss From Sale Of Asset	16M	-8M	-	1M	49M
(Gain) Loss on Sale of Investments - (CF)	3M	736M	57M	-462M	-1.75B
(Income) Loss On Equity Investments - (CF)	-80M	39M	-28M	-65M	-50M
Other Operating Activities, Total	-729M	-2.55B	-3.4B	-2.3B	-534M
Change In Accounts Receivable	-4.8B	-5.9B	-554M	23.14B	898M
Change In Inventories	-13.13B	-4.38B	3.23B	8.72B	205M
Change In Accounts Payable	7.93B	2B	-2.45B	-17.06B	4.12B
Change in Other Net Operating Assets	-4.53B	942M	4.04B	-763M	-4.99B
Cash from Operations	-7.62B	-199M	9.94B	18.45B	6.07B
Capital Expenditure	-132M	-2.37B	-306M	-231M	-1.18B
Sale of Property, Plant, and Equipment	-	18M	-	1M	4M
Cash Acquisitions	-	-	71M	-88M	-
Divestitures	-	-	-	-	1.31B
Sale (Purchase) of Intangible assets	-307M	-181M	-224M	-931M	-3.22B
Investment in Marketable and Equity Securities, Total	-321M	-99M	-197M	1.74B	385M
Net (Increase) Decrease in Loans Originated / Sold - Investing	-500M	-57M	-	-	-99M
Other Investing Activities, Total	-66M	1.44B	-54M	-509M	-181M
Cash from Investing	-1.33B	-1.25B	-710M	-15M	-2.98B
Short Term Debt Issued, Total	310M	767M	-	-	-
Long-Term Debt Issued, Total	-	515M	-	-	-
Total Debt Issued	310M	1.28B	-	-	-
Short Term Debt Repaid, Total	-	-	-273M	-427M	-188M
Long-Term Debt Repaid, Total	-	-	-110M	-284M	-213M
Total Debt Repaid	-	-	-383M	-711M	-401M
Repurchase of Common Stock	-	-	-1M	-1.02B	-1M
Common Dividends Paid	-1.19B	-1.4B	-1.9B	-2.47B	-2.6B
Common & Preferred Stock Dividends Paid	-1.19B	-1.4B	-1.9B	-2.47B	-2.6B
Other Financing Activities, Total	-	-	-2M	-1M	-1M
Cash from Financing	-883M	-115M	-2.28B	-4.2B	-3B
Foreign Exchange Rate Adjustments	290M	450M	383M	647M	72M
Miscellaneous Cash Flow Adjustments	-	629M	-1M	-1M	-
Net Change in Cash	-9.54B	-486M	7.33B	14.88B	151M
Supplemental Items
Cash Interest Paid	24M	49M	86M	95M	74M
Cash Income Tax Paid (Refund)	752M	2.6B	3.44B	2.34B	1.12B
Levered Free Cash Flow	-8.69B	-4.07B	8.65B	15.87B	351M
Unlevered Free Cash Flow	-8.68B	-4.03B	8.71B	15.92B	395M
Change In Net Working Capital	13.04B	7.92B	-3.38B	-12.88B	-720M
Net Debt Issued / Repaid	310M	1.28B	-383M	-711M	-401M

Fiscal Period: March	2022	2023	2024	2025	2026
Profitability
Return on Assets	3.29	4.02	3.39	2.3	2.21
Return on Total Capital	6.01	7.38	5.99	3.76	3.48
Return On Equity %	6.92	6.94	6.87	5.33	5.75
Return on Common Equity	6.92	6.94	6.87	5.33	5.74
Margin Analysis
Gross Profit Margin %	11.41	11.33	11.28	12.76	13.98
SG&A Margin	8.17	7.57	7.91	9.98	11.27
EBITDA Margin %	3.24	3.82	3.46	2.9	2.84
EBITA Margin %	3.06	3.6	3.21	2.54	2.46
EBIT Margin %	3.06	3.6	3.21	2.54	2.46
Income From Continuing Operations Margin %	2.18	2.06	2.21	2.18	2.48
Net Income Margin %	2.18	2.06	2.21	2.18	2.48
Net Avail. For Common Margin %	2.18	2.06	2.21	2.18	2.48
Normalized Net Income Margin	2	2.18	1.99	1.74	1.7
Levered Free Cash Flow Margin	-3.79	-1.56	3.34	7.35	0.16
Unlevered Free Cash Flow Margin	-3.79	-1.55	3.36	7.38	0.19
Asset Turnover
Asset Turnover	1.72	1.78	1.69	1.45	1.44
Fixed Assets Turnover	59.94	56.58	47.51	40.48	38.19
Receivables Turnover (Average Receivables)	3.24	3.4	3.21	3.08	3.64
Inventory Turnover (Average Inventory)	7.79	6.53	6.29	6.02	6.71
Short Term Liquidity
Current Ratio	2.01	2.08	2.15	2.55	2.37
Quick Ratio	1.36	1.4	1.55	1.87	1.82
Operating Cash Flow to Current Liabilities	-0.12	-0	0.15	0.37	0.11
Days Sales Outstanding (Average Receivables)	112.54	107.43	114.09	118.67	100.33
Days Outstanding Inventory (Average Inventory)	46.87	55.92	58.2	60.59	54.41
Average Days Payable Outstanding	85.31	86.92	91.37	96.74	83.4
Cash Conversion Cycle (Average Days)	74.11	76.43	80.92	82.52	71.33
Long Term Solvency
Total Debt/Equity	1.1	4.28	3.69	2.93	2.37
Total Debt / Total Capital	1.09	4.1	3.56	2.85	2.32
LT Debt/Equity	-	2.23	2.04	1.65	1.33
Long-Term Debt / Total Capital	-	2.14	1.96	1.6	1.3
Total Liabilities / Total Assets	46.96	47.11	44.19	37.17	38.74
EBIT / Interest Expense	292.54	167.5	93.55	60.93	73.87
EBITDA / Interest Expense	309.58	177.71	100.83	69.57	85.14
(EBITDA - Capex) / Interest Expense	304.08	135.41	97.39	67	68.45
Total Debt / EBITDA	0.11	0.34	0.36	0.42	0.37
Net Debt / EBITDA	-1.46	-0.84	-1.79	-4.9	-5.19
Total Debt / (EBITDA - Capex)	0.11	0.45	0.37	0.43	0.46
Net Debt / (EBITDA - Capex)	-1.48	-1.11	-1.86	-5.09	-6.45
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	16.4	13.61	-0.5	-16.69	-1.4
Gross Profit, 1 Yr. Growth %	19.7	12.76	-0.87	-5.76	8.03
EBITDA, 1 Yr. Growth %	93.99	33.94	-9.83	-30.23	-3.45
EBITA, 1 Yr. Growth %	105.53	33.6	-11.24	-34.13	-4.36
EBIT, 1 Yr. Growth %	105.53	33.6	-11.24	-34.13	-4.36
Earnings From Cont. Operations, 1 Yr. Growth %	113.57	7.23	6.91	-18.04	12.27
Net Income, 1 Yr. Growth %	113.57	7.23	6.9	-18.06	12.23
Normalized Net Income, 1 Yr. Growth %	99.56	23.72	-9.08	-27.23	-3.8
Diluted EPS Before Extra, 1 Yr. Growth %	113.28	7.01	6.78	-18.1	14.08
Accounts Receivable, 1 Yr. Growth %	8.23	8.65	2.36	-28.22	-0.5
Inventory, 1 Yr. Growth %	70.34	15.31	-7.07	-22.46	-0.1
Net Property, Plant and Equip., 1 Yr. Growth %	-3.01	44.47	0.5	-4.9	14.41
Total Assets, 1 Yr. Growth %	12.3	7.15	3.3	-8.99	8.67
Tangible Book Value, 1 Yr. Growth %	6.89	6.79	8.94	1.38	2.45
Common Equity, 1 Yr. Growth %	6.93	6.86	8.98	2.44	5.96
Cash From Operations, 1 Yr. Growth %	-493.14	-97.39	-5.1K	85.61	-67.12
Capital Expenditures, 1 Yr. Growth %	34.69	1.69K	-87.08	-24.51	412.99
Levered Free Cash Flow, 1 Yr. Growth %	-666.38	-53.2	-312.66	83.43	-97.79
Unlevered Free Cash Flow, 1 Yr. Growth %	-660.16	-53.53	-315.89	82.91	-97.52
Dividend Per Share, 1 Yr. Growth %	0	32.14	43.24	0	30.19
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	-0.21	15	6.32	-8.95	-9.36
Gross Profit, 2 Yr. CAGR %	1.4	16.18	5.73	-3.35	0.9
EBITDA, 2 Yr. CAGR %	10.54	61.2	9.9	-20.68	-17.93
EBITA, 2 Yr. CAGR %	12.37	65.71	8.9	-23.54	-20.63
EBIT, 2 Yr. CAGR %	12.37	65.71	8.9	-23.54	-20.63
Earnings From Cont. Operations, 2 Yr. CAGR %	13.86	51.33	7.07	-6.39	-4.07
Net Income, 2 Yr. CAGR %	13.86	51.33	7.06	-6.41	-4.1
Normalized Net Income, 2 Yr. CAGR %	12.9	57.13	6.06	-18.66	-16.33
Diluted EPS Before Extra, 2 Yr. CAGR %	13.68	51.07	6.9	-6.48	-3.34
Accounts Receivable, 2 Yr. CAGR %	2.7	8.44	5.46	-14.28	-15.49
Inventory, 2 Yr. CAGR %	25.5	40.15	3.52	-15.11	-11.99
Net Property, Plant and Equip., 2 Yr. CAGR %	-4.44	18.37	20.5	-2.24	4.31
Total Assets, 2 Yr. CAGR %	4.82	9.7	5.2	-3.04	-0.55
Tangible Book Value, 2 Yr. CAGR %	5.12	6.84	7.86	5.09	1.91
Common Equity, 2 Yr. CAGR %	5.2	6.9	7.92	5.66	4.19
Cash From Operations, 2 Yr. CAGR %	13.3	-67.96	14.2	862.96	-21.88
Capital Expenditures, 2 Yr. CAGR %	-15.53	391.67	52.26	-68.77	96.79
Levered Free Cash Flow, 2 Yr. CAGR %	25.78	62.8	-0.24	97.51	-79.86
Unlevered Free Cash Flow, 2 Yr. CAGR %	25.42	61.35	0.17	98.72	-78.7
Dividend Per Share, 2 Yr. CAGR %	0	14.95	37.58	19.68	14.1
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	-1.58	4.2	9.58	-1.98	-6.5
Gross Profit, 3 Yr. CAGR %	1.32	5.06	10.2	1.75	0.31
EBITDA, 3 Yr. CAGR %	6.7	17.85	32.82	-5.55	-15.31
EBITA, 3 Yr. CAGR %	7.68	19.04	34.58	-7.91	-17.62
EBIT, 3 Yr. CAGR %	7.68	19.04	34.58	-7.91	-17.62
Earnings From Cont. Operations, 3 Yr. CAGR %	10.28	11.61	34.78	-2.05	-0.54
Net Income, 3 Yr. CAGR %	10.28	11.61	34.78	-2.07	-0.57
Normalized Net Income, 3 Yr. CAGR %	9.19	16.4	30.94	-6.46	-13.98
Diluted EPS Before Extra, 3 Yr. CAGR %	10.1	11.41	34.57	-2.18	-0.08
Accounts Receivable, 3 Yr. CAGR %	-0.1	4.65	6.38	-7.23	-9.91
Inventory, 3 Yr. CAGR %	11.37	22.01	22.21	-5.99	-10.38
Net Property, Plant and Equip., 3 Yr. CAGR %	-6.33	9.68	12.09	11.35	3.02
Total Assets, 3 Yr. CAGR %	2.03	5.59	7.52	0.24	0.71
Tangible Book Value, 3 Yr. CAGR %	4.38	5.67	7.53	5.65	4.2
Common Equity, 3 Yr. CAGR %	4.4	5.75	7.59	6.06	5.76
Cash From Operations, 3 Yr. CAGR %	19.39	-67.76	72.44	34.27	212.4
Capital Expenditures, 3 Yr. CAGR %	-5.62	133.95	46.16	20.51	-20.62
Levered Free Cash Flow, 3 Yr. CAGR %	22.11	-9.54	77.97	22.22	-55.82
Unlevered Free Cash Flow, 3 Yr. CAGR %	21.83	-9.92	77.79	22.43	-53.9
Dividend Per Share, 3 Yr. CAGR %	0	9.74	23.7	23.7	23.09
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	0.89	1.94	1.51	-1.27	1.57
Gross Profit, 5 Yr. CAGR %	3.46	3.83	3.06	1.61	6.38
EBITDA, 5 Yr. CAGR %	17.7	12.22	7.97	0.59	9.56
EBITA, 5 Yr. CAGR %	20.78	13.05	8.16	-0.27	8.95
EBIT, 5 Yr. CAGR %	20.78	13.05	8.16	-0.27	8.95
Earnings From Cont. Operations, 5 Yr. CAGR %	29.24	8.38	8.99	4.03	17.64
Net Income, 5 Yr. CAGR %	29.24	8.38	8.98	4.02	17.62
Normalized Net Income, 5 Yr. CAGR %	25.18	12.48	7.93	0.85	9.46
Diluted EPS Before Extra, 5 Yr. CAGR %	29.06	8.21	8.81	3.88	17.89
Accounts Receivable, 5 Yr. CAGR %	2.4	1.58	2.09	-3.38	-2.98
Inventory, 5 Yr. CAGR %	11.96	8.38	8.16	5.53	7.17
Net Property, Plant and Equip., 5 Yr. CAGR %	-5.07	2.95	3.6	4.74	8.91
Total Assets, 5 Yr. CAGR %	2.8	2.47	3.29	2.05	4.21
Tangible Book Value, 5 Yr. CAGR %	4.16	4.5	5.75	5.44	5.25
Common Equity, 5 Yr. CAGR %	4.16	4.52	5.79	5.72	6.21
Cash From Operations, 5 Yr. CAGR %	10.63	-47.16	17.29	25.45	25.63
Capital Expenditures, 5 Yr. CAGR %	-9.63	85.11	14.28	4.54	64.63
Levered Free Cash Flow, 5 Yr. CAGR %	13	-7.34	12.63	23.63	-25.56
Unlevered Free Cash Flow, 5 Yr. CAGR %	12.84	-7.44	12.65	23.62	-23.91
Dividend Per Share, 5 Yr. CAGR %	4.94	9.98	13.61	13.61	19.77